Analysis of extracellular vesicles generated from monocytes under conditions of lytic cell death.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 05 2019
Historique:
received: 02 01 2019
accepted: 02 05 2019
entrez: 19 5 2019
pubmed: 19 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Extracellular vesicles (EVs) are an important class of membrane-bound structures that have been widely investigated for their roles in intercellular communication in the contexts of tumor progression, vascular function, immunity and regenerative medicine. Much of the current knowledge on the functions of EVs pertains to those derived from viable cells (e.g. exosomes and microvesicles) or apoptotic cells (e.g. apoptotic bodies) whilst the generation of EVs from dying cells under non-apoptotic conditions remains poorly characterized. Herein, the release of EVs from THP-1 monocytes under conditions of primary necrosis, secondary necrosis and pyroptosis, was investigated. A comprehensive analysis of THP-1-derived EVs revealed that cells undergoing lytic forms of cell death generated a high number of EVs compared with viable or apoptotic cells in vitro. Differential centrifugation via 16,000 g and 100,000 g revealed that dying THP-1 cells release both medium and small EVs, respectively, consistent with the known characteristics of microvesicles and/or exosomes. In addition, large EVs isolated via 2000 g centrifugation were also present in all samples. These findings suggest that lytic cell death under both sterile and non-sterile inflammatory conditions induces monocytes to generate EVs, which could potentially act as mediators of cell-to-cell communication.

Identifiants

pubmed: 31101910
doi: 10.1038/s41598-019-44021-9
pii: 10.1038/s41598-019-44021-9
pmc: PMC6525174
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7538

Références

Immunity. 2012 Dec 14;37(6):1009-23
pubmed: 23219391
EMBO Rep. 2002 Jul;3(7):604-9
pubmed: 12101090
Nat Rev Rheumatol. 2014 Jun;10(6):356-64
pubmed: 24535546
J Gen Virol. 2013 Oct;94(Pt 10):2215-2220
pubmed: 23884363
Nat Rev Rheumatol. 2010 May;6(5):280-9
pubmed: 20431553
FEBS Lett. 2010 Nov 19;584(22):4491-9
pubmed: 20974143
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Nat Rev Immunol. 2017 Jun;17(6):349-362
pubmed: 28436425
J Extracell Vesicles. 2017 Jul 3;6(1):1340746
pubmed: 28717426
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E961-E969
pubmed: 28096356
Cell Host Microbe. 2014 Aug 13;16(2):249-256
pubmed: 25121752
Trends Cell Biol. 2017 Feb;27(2):151-162
pubmed: 27647018
Nat Immunol. 2010 Dec;11(12):1136-42
pubmed: 21057511
J Biol Chem. 2005 Jun 17;280(24):23349-55
pubmed: 15826944
Front Physiol. 2018 Oct 23;9:1479
pubmed: 30405435
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701
pubmed: 24434149
Annu Rev Immunol. 1994;12:991-1045
pubmed: 8011301
Elife. 2014 Apr 01;3:e01808
pubmed: 24692446
Sci Rep. 2018 Feb 28;8(1):3788
pubmed: 29491424
Sci Rep. 2018 Feb 19;8(1):3287
pubmed: 29459716
Trends Biochem Sci. 2016 Dec;41(12):1012-1021
pubmed: 27669650
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Nat Commun. 2015 Jun 15;6:7439
pubmed: 26074490
Nature. 2014 Mar 20;507(7492):329-34
pubmed: 24646995
J Pharm Sci. 2016 Nov;105(11):3366-3375
pubmed: 27663383
PLoS One. 2009 Sep 25;4(9):e7140
pubmed: 19779610
Nat Rev Microbiol. 2009 Feb;7(2):99-109
pubmed: 19148178
PLoS One. 2011 Feb 25;6(2):e16899
pubmed: 21364924
Sci Rep. 2017 Jun 9;7(1):3143
pubmed: 28600520
Front Immunol. 2018 Dec 04;9:2842
pubmed: 30564238
Front Immunol. 2015 Nov 20;6:588
pubmed: 26635802
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Cell Microbiol. 2016 Nov;18(11):1518-1524
pubmed: 27564529
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
Nat Rev Cardiol. 2010 Feb;7(2):77-86
pubmed: 20065951
Nat Protoc. 2016 Apr;11(4):655-63
pubmed: 26938116
Small GTPases. 2017 Oct 2;8(4):220-232
pubmed: 27494381
Int J Mol Sci. 2017 May 29;18(6):
pubmed: 28555055
J Leukoc Biol. 2007 Jan;81(1):6-14
pubmed: 17005907
J Immunol. 2002 Nov 15;169(10):6020-9
pubmed: 12421989
Nat Rev Immunol. 2008 Apr;8(4):279-89
pubmed: 18340345
J Immunol. 2016 Oct 15;197(8):3315-3325
pubmed: 27638862
J Proteome Res. 2017 Jan 6;16(1):170-178
pubmed: 27684284
Front Immunol. 2018 Mar 15;9:534
pubmed: 29599781
Nat Commun. 2017 Jan 03;8:14128
pubmed: 28045099
J Immunol. 2012 Jan 1;188(1):135-45
pubmed: 22116825
J Proteome Res. 2014 May 2;13(5):2468-77
pubmed: 24670152
Immunity. 2001 Nov;15(5):825-35
pubmed: 11728343
Immunology. 2013 Sep;140(1):22-30
pubmed: 23621371
Apoptosis. 2017 Oct;22(10):1189-1204
pubmed: 28861714
Cell Death Dis. 2018 Jun 20;9(7):723
pubmed: 29925877

Auteurs

Amy A Baxter (AA)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia. a.baxter@latrobe.edu.au.

Thanh Kha Phan (TK)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia.

Eric Hanssen (E)

Advanced Microscopy Facility, Bio21 Molecular Science and Biotechnology Institute, the University of Melbourne, Melbourne, Victoria, 3010, Australia.

Michael Liem (M)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia.

Mark D Hulett (MD)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia.

Suresh Mathivanan (S)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia.

Ivan K H Poon (IKH)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia. i.poon@latrobe.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH